Roger Ho
Professor and Senior Consultant Psychiatrist at the National University of Singapore and National University Hospital
Data updated
Research Footprint
Roger Ho appears in 10 tracked papers (2020–2024), most studied alongside Ketamine, Esketamine and Psilocybin, across Depressive Disorders, Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD).
Most-cited paper: Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation (676 citations).
Frequent co-authors: Jonathan Rosenblat, Roger McIntyre and Joseph Vincenzo.
Background & Research
Roger Ho Chun Man is a psychiatrist and academic clinician based at the National University of Singapore (NUS) and National University Hospital (NUH). He serves as Professor and Senior Consultant Psychiatrist, and is also Research Director for the Department of Psychological Medicine and Director of the fNIRS Group at iHealthtech, NUS. His research interests include major depressive disorder, psychiatric diagnosis, and technology-enabled precision psychiatry, and he has published extensively in peer-reviewed journals.
Key Impact
He is a highly cited psychiatrist whose work spans depression, suicidality, ketamine/esketamine, and related psychiatric outcomes, making him relevant to both psychedelic and rapid-acting antidepressant research.
Collaboration Network
25 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Roger Ho is associated with.